Cargando…
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review
BACKGROUND: Vaccines are critical cost-effective tools to control the coronavirus disease 2019 (COVID-19) pandemic. However, the emergence of variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may threaten the global impact of mass vaccination campaigns. AIMS: The objective...
Autores principales: | Fiolet, Thibault, Kherabi, Yousra, MacDonald, Conor-James, Ghosn, Jade, Peiffer-Smadja, Nathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548286/ https://www.ncbi.nlm.nih.gov/pubmed/34715347 http://dx.doi.org/10.1016/j.cmi.2021.10.005 |
Ejemplares similares
-
COVID-19 vaccine boosters: What do we know so far?
por: Kherabi, Yousra, et al.
Publicado: (2021) -
Dose de rappel du vaccin COVID-19 : que savons-nous à ce jour ?
por: Kherabi, Yousra, et al.
Publicado: (2022) -
Omicron SARS-CoV-2 variant: What we know and what we don’t
por: Ferré, Valentine Marie, et al.
Publicado: (2022) -
COVID-19 : les thérapeutiques
por: KHERABI, Yousra, et al.
Publicado: (2022) -
COVID-19 vaccines: A race against time
por: Peiffer-Smadja, Nathan, et al.
Publicado: (2021)